In order to achieve greater development goals, the company invested and built a modern new factory building covering an area of about 180 mu in Yixing Environmental Protection Science and Technology Industrial Park. Adopt the most advanced production equipment at home and abroad, and rationally arrange the production, storage, administration and living quarters according to the new national requirements such as good manufacturing practice, Specification for Clean Factory Facilities, Specification for Hygienic Pre-evaluation of Construction Projects of Industrial Enterprises, and Specification for Fire Prevention in Architectural Design, so as to make the functional division clear and separate people flow and logistics, and build the factory into a garden-style modern factory that meets GMP standard 20 10.
The expansion of the company is divided into two stages. The investment in the first phase of the project is 228 million yuan. Projects under construction include all existing dosage forms and dropping pills workshops, soft capsule workshops and health food workshops. At present, the plant and equipment are basically in place, and it is expected to be completed and put into operation in 20 1 1 year1February. The second phase of the project will invest 250 million yuan to build two freeze-dried powder injection production lines and a multifunctional R&D center, focusing on biopharmaceuticals and traditional Chinese medicine.
Based on the relocation of the original workshop, the company expanded its production capacity, added new dosage forms and enhanced its competitive advantage. After the expansion, the annual output of products: 5 billion tablets, 500 million capsules, 40 million bottles (bags) of infusion, 200 million small-volume injections, 50 million bags of traditional Chinese medicine pills, 5 million bottles of external medicine, 50 tons of raw materials, 200 million soft capsules, 5,000 kilograms of dripping pills and 6,543,800,000 bottles of freeze-dried powder injections, with an output value of 5,654,380+.
Over the years, the company has been adhering to the corporate philosophy of "quality first, pursuit of human health", carrying forward the corporate spirit of "respecting morality, being conscientious and constantly striving for self-improvement", and following the business purposes of "creating brands with quality, surviving with integrity, seeking benefits with management and seeking development with technology". The company has been rated as a high-tech enterprise, a contract-abiding and credit-abiding enterprise in Jiangsu Province and an AAA-level credit enterprise in Jiangsu Province for many years.